Ge Gao

Dr. Ge Gao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in International Dental Journal
Verified
Journal Article
Open access
JHJiale Han
Jiale Han
YLYihan Liu
Yihan Liu
XGXiaoyang Guo
Xiaoyang Guo
GGGe Gao
Ge Gao
QWQihui Wu
Qihui Wu
Introduction and aims Evidence suggests an association between periodontitis and neurodegenerative diseases, but a comprehensive analysis of research trends remains absent. Therefore, we aim to identify research trends and hotspots on the comorbidity between periodontitis and neurodegenerative diseases, understand mechanisms, provide guidance for subsequent studies and show its clinical translational possibility. Methods: A bibliometric analysis covering 1982 to 2023 was conducted using the Web of Science Core Collection. English-language articles range from January 1, 1982 to November 30, 2023 were analyzed. Data were downloaded on November 30, 2023 and analyzed on December, 2023. Data visualization and statistical analysis were performed to identify trends of annual publications, countries, sources, institutions, authors, most cited articles, and keywords by using Microsoft Excel, VOSviewer, Citespace, R-bibliometrix and Origin Pro. Results: A total of 1,238 articles from 1982 to 2023 on the comorbidity between periodontitis and neurodegenerative diseases were identified. Annual publications showed an upward trend. The United States, University College of London, BRAIN and Shy, Michael E. were the leading nation, affiliation, source and author, respectively. The United States, NEUROLOGY, and Curtis Maurice A. were the most cited nation, source, and author. Keywords network analysis highlighted 'Charcot-Marie-Tooth Disease', 'Alzheimer's Disease' and 'Periodontitis' as focal points. Detection of keywords citation bursts demonstrated 'Porphyromonas gingivalis' and 'Cognitive Dysfunction' as hot topics in recent research. Conclusions: In recent years, emerging interests of the comorbidity between periodontitis and neurodegenerative diseases (NDs) are growing. Our study enhances the understanding of recent research trends of periodontitis and NDs and provides valuable perspectives within this expanding field, offering new insights into research trends regarding the interplay between 'Porphyromonas gingivalis' and 'Cognitive Dysfunction'. Further research of the molecular mechanisms between P. gingivalis-induced periodontitis, neuroinflammation, that leads neurodegeneration are clearly warranted.

29 October 2025 in Brain and Behavior
Verified
Journal Article
Open access
XZXinyue Zhang
Xinyue Zhang
YMYizhao Ma
Yizhao Ma
GGGe Gao
Ge Gao
QWQihui Wu
Qihui Wu
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the aggregation and propagation of alpha‐synuclein (α‐syn), processes that contribute to neuronal dysfunction and cell death. Although substantial progress has been made in understanding α‐syn pathology, a comprehensive bibliometric evaluation of global trends in this field remains lacking. This study aims to systematically map the research landscape surrounding α‐syn aggregation and propagation in PD, offering insights into its molecular mechanisms and clinical relevance. Methods: A bibliometric analysis was conducted using data retrieved from the Web of Science Core Collection (WoSCC) spanning 2005 to 2024. The data were processed and analyzed with R‐Bibliometrix, VOSviewer, and CiteSpace to quantify publication trends, international collaborations, influential authors and institutions, journal impact, and keyword co‐occurrence networks. Results: A total of 3220 relevant articles were identified. The number of annual publications steadily increased, reflecting growing scholarly interest. The United States, China, and the United Kingdom emerged as leading contributors. Robust international collaborations were observed, especially among Western countries, with the University of California System identified as the most prolific institution. Two primary thematic clusters were revealed: (1) “aggregation,” focusing on the roles of “mitochondria” and “lysosomes,” and (2) “propagation,” highlighting the involvement of “exosomes” and “microglia.” Emerging research frontiers included “biomarkers” and “neuroinflammation,” with a recent trend shifting toward studies on the propagation of α‐syn. Conclusion: This study underscores a paradigm shift in PD research from α‐syn aggregation to propagation, emphasizing the significance of exosomes, microglia, and systemic inflammation in disease pathogenesis. These findings provide a comprehensive roadmap for future research, highlighting the need for interdisciplinary collaboration and the development of targeted therapeutic strategies.

20 May 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
MZMing Zhang
Ming Zhang
WYWenshuo Yang
Wenshuo Yang
JWJunxin Wang
Junxin Wang
BZBiqi Zou
Biqi Zou
JZJialin Zheng
Jialin Zheng
GGGe Gao
Ge Gao
Amyotrophic lateral sclerosis (ALS) remains a major therapeutic challenge, with immune dysregulation increasingly recognized as a critical driver of disease progression. Despite extensive mechanistic research, no immunotherapeutic approach has achieved consistent disease-modifying effects, raising questions about whether this translational gap reflects biological complexity or structural misalignment within the research ecosystem. To characterize the intellectual evolution of ALS immunotherapeutics research, identify immune targets with translational potential, and evaluate collaboration patterns that may influence translational efficiency, we performed a bibliometric analysis of 2,256 publications indexed in Web of Science and Scopus using network-based approaches including co-citation clustering, keyword co-occurrence, and citation burst detection implemented in CiteSpace, VOSviewer, and R-Bibliometrix. Publication output increased 8.4-fold over the study period, delineating three developmental phases. Thematic analyses revealed a shift from early emphasis on microglial biology and SOD1-based models toward recent focus areas including the gut-brain axis, C9orf72-associated immune dysregulation, and advanced immunomodulatory strategies. Collaboration networks remain predominantly regional despite strong contributions from the United States, Europe, and Asia, with limited integration between mechanistic research groups and clinical trial consortia. Among immune-directed therapeutic strategies, regulatory T cell modulation and microglial-targeted approaches exhibit the highest translational readiness. These findings suggest that the lack of effective ALS immunotherapeutics reflects not only biological complexity but also structural and strategic misalignment within the research ecosystem. This bibliometric analysis provides a systems-level framework to guide more integrated translational strategies in ALS immunotherapeutics development.

1 April 2026 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
MZMing Zhang
Ming Zhang
WSWeihao Sun
Weihao Sun
YMYizhao Ma
Yizhao Ma
JZJialin Zheng
Jialin Zheng
QWQihui Wu
Qihui Wu
GGGe Gao
Ge Gao
Background: Neurotransmitter signaling influences cancer initiation, progression, and therapy response. We systematically characterized the field’s intellectual structure, thematic evolution, and translational trajectory. Methods: We analyzed 2,823 Web of Science articles [2000–2025] with CiteSpace and Bibliometrix, and reviewed 76 interventional trials from ClinicalTrials.gov to assess translational activity, drug-class distribution, and trial design trends. Results: Annual output nearly tripled, with >50% of papers published after 2020. The US led productivity (26.2%) and impact; China showed rapid output growth (18.1%). Oncology trials with tumor efficacy endpoints were dominated by β-adrenergic antagonists (33%), histone deacetylase (HDAC) inhibitors (16%), selective serotonin reuptake inhibitors (SSRIs) (22%), and dopamine modulators (13%). Since 2018, immunotherapy combinations increased (8 trials). Trials were skewed toward early-phase, and trial design heterogeneity and limited biomarker integration were common. Translational linkage was limited: only 4.5% of publications connected to identifiable trials. The neurotransmitter-immune axis emerged as a central translational theme. Conclusions: Neurotransmitter-cancer research has expanded rapidly but shows substantial translational attrition. Findings support continued evaluation of β-blockers in late-phase trials, prioritized testing of SSRI-immunotherapy combinations, and exploration of underrepresented GABAergic and cholinergic pathways. We recommend harmonized preclinical-to-clinical pipelines and accelerated biomarker development to improve translation. This evidence-based map can guide targeted translational strategies in neurotransmitter-directed oncology and precision oncology.